Hypothetical case - For market research purposes only
UNITED BY CANCER
About UsOur TreatmentsOur Science
Our StoryEventsResources
Profile
Search
You are about to enter Our Science, which contains information concerning our Research & Development activities as well as other information produced by our Medical Affairs function.
You are about to enter Our Treatments, which contains information promoting the use of our approved medicines.

The DREAMM-12 Clinical Trial

Download pdf
[432 Kb]

Learn about DREAMM-12, an ongoing study assessing the PK, safety, and tolerability of belantamab mafodotin-blmf monotherapy in participants with RRMM who have had at least 2 lines of prior treatment and have either normal or varying degrees of impaired renal functions.

${articleImageText}

${articleLinkText}